The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1a/1b trial in relapsed/refractory T-cell non-Hodgkin lymphoma to determine the safety profile, pharmacology, and maximum tolerated dose of ST-001, an intravenous fenretinide phospholipid suspension (12.5 mg/mL).
 
Oleg Akilov
Speakers' Bureau - Helsinn Therapeutics; Kyowa Kirin International; Ortho Dermatologics
Research Funding - Mallinckrodt/Therakos
 
Auris Huen
Consulting or Advisory Role - Blueprint Medicines
Research Funding - crispr therapeutics; Innate Pharma; Kymera; Kyowa Kirin International; SciTech Development LLC; Soligenix
 
Barbara Pro
Honoraria - Bio Secura
Research Funding - Ono Pharmaceutical (Inst); SciTech Development LLC (Inst)
Travel, Accommodations, Expenses - Seagen; takeda
 
Dipenkumar Modi
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; AstraZeneca (I); Daiichi Sankyo/Lilly (I); Genentech (I); Genmab; Seagen
Speakers' Bureau - BeiGene
Research Funding - AstraZeneca (Inst); Genentech (Inst); Genmab (Inst); Karyopharm Therapeutics (Inst)
 
Ann Mohrbacher
No Relationships to Disclose
 
Brad Haverkos
No Relationships to Disclose
 
Lou Scarmoutzos
No Relationships to Disclose
 
Michael Burns
No Relationships to Disclose
 
Earle Holsapple
No Relationships to Disclose
 
Ken Massey
No Relationships to Disclose
 
Ralph Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - Leidos; SciTech Development LLC
Consulting or Advisory Role - SciTech Development Inc
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; named inventor on EU patent EP3430051B1; Named Inventor on US Patent 9,644,037; Named inventor on US Patent US8709379 B2
 
Yamini Donekal
No Relationships to Disclose
 
Ali Moiin
No Relationships to Disclose